AADI - Aadi Bioscience GAAP EPS of -$0.52 beats by $0.19 revenue of $5.23M beats by $0.58M
2023-03-28 08:05:06 ET
- Aadi Bioscience press release ( NASDAQ: AADI ): Q4 GAAP EPS of -$0.52 beats by $0.19 .
- Revenue of $5.23M (+423.0% Y/Y) beats by $0.58M .
- Cash, cash equivalents and short-term investments as of December 31, 2022 were $172.6 million as compared to $148.9 million as of December 31, 2021, which is expected to fund operations into 2025 based on current plans.
For further details see:
Aadi Bioscience GAAP EPS of -$0.52 beats by $0.19, revenue of $5.23M beats by $0.58M